KalVista Pharmaceuticals, Inc. (KALV) Deferred Tax Assets, Valuation Allowance USD 2013 - 2023

Historical data

Taxonomy & unit: us-gaap: USD
Description: Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary: KalVista Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2013 to 2023.
KalVista Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending April 30, 2023 was $45.3 M, a 60.5% increase year-over-year.

Deferred Tax Assets, Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2023	$45.3 M	+$17.1 M	+60.5%	Apr 30, 2023	10-K	2023-07-10
Q1 2022	$28.2 M	+$11.2 M	+65.7%	Apr 30, 2022	10-K	2023-07-10
Q1 2021	$17 M	+$7.5 M	+78.7%	Apr 30, 2021	10-K	2022-07-07
Q1 2020	$9.53 M	+$1.14 M	+13.5%	Apr 30, 2020	10-K	2021-07-13
Q1 2019	$8.39 M	+$1.56 M	+22.8%	Apr 30, 2019	10-K	2020-07-01
Q1 2018	$6.84 M	+$952 K	+16.2%	Apr 30, 2018	10-K	2019-07-16
Q1 2017	$5.88 M	+$3.04 M	+107%	Apr 30, 2017	10-K	2018-07-30
Q1 2016	$2.85 M			Apr 30, 2016	10-K	2017-07-27
Q4 2015	$28.8 M	+$10.5 M	+57.8%	Dec 31, 2015	10-K	2016-03-30
Q4 2014	$18.2 M	+$3.98 M	+27.9%	Dec 31, 2014	10-K	2016-03-30
Q4 2013	$14.3 M			Dec 31, 2013	10-K	2016-03-30

* An asterisk sign (*) next to the value indicates that the value is likely invalid.